News Sentiment

OSL sentiment intelligence

OncoSil Medical Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 39 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.80 Week of 19 Jun 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+40.7% over one week, +55.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

OncoSil Medical (ASX:OSL): Cancer-Treatment Stock Jumps as Biotech Traders Return

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 40.7% Price confirming higher
Trend fit Trend inactive 55.9% over four weeks
Fair value -66.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 38
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
Kalkine 6
intelligentinvestor.com.au 4
smallcaps.com.au 2
StockStory 2
Barron's 1
Stocks Down Under 1
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 15
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 39